Terazosin Capsule
Product Images NDC 68788-4064

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 68788-4064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure 01)

Image Description (Figure 01)
This data indicates the mean change in total symptom score from baseline for placebo and terazosin groups. Additionally, it shows the mean increase in peak flow rate in milliliters per second from baseline for terazosin and placebo groups over a span of three months in Study 1.*
FDA Label Image

Image Description (Figure 02)

Image Description (Figure 02)
This is a statistical description of the mean change in total symptom scores from baseline in a long-term, open-label study with 494 participants. The data includes measurements at different time points up to 30 months.*
FDA Label Image

Image Description (Figure 03)

Image Description (Figure 03)
This is a chart showing the mean change in peak flow rate from baseline in a long-term, open-label, non-placebo controlled study with a total of 494 participants. The study was carried out over a period of 30 months, with measurements taken at various time points. The chart displays the mean change in milliliters per second (mL/sec) over the duration of the study.*
FDA Label Image

Terazosin Hydrochloride Capsules 2mg (Image006)

Terazosin Hydrochloride Capsules 2mg (Image006)
This text contains information about Terazosin Hydrochloride Capsules, a medication prescribed to patients for conditions requiring a 2mg dosage. The capsules are generic for Hytrin and should be stored at a temperature of 20°-25°C while being protected from light and moisture. It mentions a warning that federal law prohibits the transfer of this drug to anyone other than the prescribed patient. The capsules are yellow, capsule-shaped, and have "TEZ" printed on them. The manufacturer listed is OrBi Pharmaceuticals Pvt. Ltd, and it includes details such as the package size, expiration date, and lot number.*
FDA Label Image

Image Description (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.